In addition to CMT2D, heterozygous GARS1 mutations have been linked to related peripheral neuropathies characterized by selective motor axonal degeneration and lacking sensory involvement, including distal hereditary motor neuropathy type V (dHMN-V) [1, 5] and infantile spinal muscular atrophy (iSMA) [8, 9]. Here, GARS1 is linked to peripheral neuropathy.